Z-2923-2020 Class II Terminated

Recalled by RANDOX LABORATORIES, LTD. — Crumlin Colorado Antrim, N/A

FDA device recall Z-2923-2020 was initiated by RANDOX LABORATORIES, LTD. on July 10, 2020 and is designated Class II. Reason for recall: Amylase AY3805 batch 480449 and Pancreatic Amylase AY3855 batch 480483 have failed to meet the quoted performance claims prior to expiry on 28th Sept 2020. The recall status is terminated (terminated June 17, 2021). Affected quantity: 1497 units.

Recall Details

Product Type
Devices
Report Date
September 9, 2020
Initiation Date
July 10, 2020
Termination Date
June 17, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1497 units

Product Description

Amylase AY3805 batch 480449 Amylase Ethylidene Blocked-pNPG7 Reagent

Reason for Recall

Amylase AY3805 batch 480449 and Pancreatic Amylase AY3855 batch 480483 have failed to meet the quoted performance claims prior to expiry on 28th Sept 2020.

Distribution Pattern

New Mexico, Massachusetts, WV. Foreign distribution to Bolivia BOSNIA AND HERZEGOVINA Brazil Colombia Costa Rica Cyprus Egypt France Greece Grenada India Iraq Italy Jordan Kazakhstan Kenya Lithuania Mauritius Nepal Nigeria Pakistan Peru Philippines Poland Portugal Qatar Romania Russia South Africa Thailand The Bahamas Turkey UAE UK Vietnam

Code Information

AY3805 GTIN 05055273200607